Print
Email
Print Edition StoriesThursday, December 31, 2009
Zoll defibrillator/CO monitor cleared by FDA
By Mass High Tech staff
MHT's Julie Donnelly: Pharmaceuticals find drug development partners in colleges
Robotic surgery gains traction
MHT's Marc Songini: Technology to keep seniors healthy
Zoll Medical Corp., a medical device maker in Chelmsford, has received U.S. Food and Drug Administration 510(k) clearance for its Zoll E Series Monitor/Defibrillator with carbon monoxide monitoring.
The product is designed to detect carbon monoxide poisoning with a button push, enabling early treatment. The E Series has a see-through CPR filter, Real CPR Help for real-time feedback of chest compressions, and wireless 12-lead transmission.
Zoll (Nasdaq: ZOLL) makes devices and associated software for cardiac pacing, defibrillation, circulation, ventilation, and fluid resuscitation. It sells its products in more than 140 countries.
In August, Zoll Medical received FDA approvel to market and sell its new model of the LifeVest wearable defibrillator.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
